Dawn Carter Bir - 15 May 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role
Chief Commercial Officer
Signature
/s/ Tracy Herson, attorney-in-fact
Issuer symbol
RETA
Transactions as of
15 May 2023
Transactions value $
-$109,829
Form type
4
Filing time
17 May 2023, 16:21:18
Previous filing
15 Mar 2023
Next filing
02 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RETA Class A common stock Sale -$76.1K -894 -2.78% $85.09 31.3K 15 May 2023 Direct F1
transaction RETA Class A common stock Sale -$33.8K -417 -1.33% $80.96 30.9K 16 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.